Mohamed Elrishi

Learn More
OBJECTIVE To compare recent U.S. and U.K. guidelines on gestational diabetes mellitus (GDM). RESEARCH DESIGN AND METHODS The guidelines from the American Diabetes Association, the American College of Obstetricians and Gynecologists, and the National Institute for Health and Clinical Excellence (NICE) in the U.K. were collated and compared using a general(More)
RESEARCH DESIGN AND METHODS — The guidelines from the American Diabetes Association, the American College of Obstetricians and Gynecologists, and the National Institute for Health and Clinical Excellence (NICE) in the U.K. were collated and compared using a general inductive approach. RESULTS — There are substantial differences in the recommendations(More)
BACKGROUND Insulin glargine (Lantus) was the first recombinant-DNA long-acting insulin analogue to be licensed for use in the treatment of diabetes mellitus. OBJECTIVE This review considers the use of insulin glargine in the treatment of type 2 diabetes (T2DM). METHODS Medline, Cochrane and Embase databases were searched for relevant papers from the(More)
  • 1